COVID-19 Impact on Neuroscience Antibodies & Assays Market By Key Manufacturers, By Type (Consumables, Instruments), and Application (Research, In Vitro Diagnostics, Drug Discovery and Development) and and By Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa) - Global Outlook to 2026
Report ID: 392350 | May 2020 | No. of Pages: 120 |
Covid-19 Impact Analysis & Forecast
Global Neuroscience Antibodies & Assays Market size is estimated to record USD 5.59 billion by 2026, at a Compound Annual Growth Rate (CAGR) of 10.2%.

Neuroscience Antibodies & Assays Market report (2019-2026) includes global market size, trends, company overview, competition analysis, and forecast. The global market is projected to record USD 2.83 Billion in 2019.

The market report includes Neuroscience Antibodies & Assays market definition, segmentation, executive summary, value chain analysis, porter’s analysis, research methodology and new industry trends which includes drivers, restraints and market opportunities. Other section includes regional analysis which is conducted on various factors such as cost of the product/services, raw material supplies, production capacities, availability and demand analysis. Further section includes analysis and opportunity assessment for key companies. This section includes competition analysis, market share analysis, key developments of the industry, and company profiling. Within company profiling, detailed analysis of key players including company overview, financial information analysis, product offerings, and recent development of company. This also includes SWOT analysis that highlights the current position of company among competitors and in market.
Neuroscience Antibodies & Assays Market Dynamics
The market report comprises of market dynamics/trends section that includes driving factors, restraints, and opportunities faced by the market players and stakeholders. These market trends includes core factors such as driving factor and restraining factor and extrinsic factors such as opportunities. These factors are not only confined with the current market situation as well as with the forecasted period.
Neuroscience Antibodies & Assays Market Competitive Landscape
The key companies in Neuroscience Antibodies & Assays Market are Thermo Fisher Scientific (US), Abcam (UK), Bio-Rad (US), Merck KGaA (Germany), BioLegend (US), Cell Signaling Technology (US), F. Hoffmann-La Roche (Switzerland), GenScript (China), Rockland Immunochemicals (US), Santa Cruz Biotechnology (US), Siemens (Germany), Tecan (Switzerland).
Focus Areas of Market
• Global Market Analysis (2019-2026)
• Cost Analysis
• Market Growth Factors
• Market Strategies
• Key Companies Analysis
• Industry Growth Analysis
Regional Analysis
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa
Company Profile Inclusions
• Business Overview
• Financial Information
• Market Share Analysis
• Recent News
• SWOT Analysis
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations

Chapter 3. Executive Summary

Chapter 4. Market Outlook
4.1. Market Dynamics
4.1.1. Market Drivers
4.1.2. Market Restraints
4.1.3. Market Opportunities
4.2. Porter’s Analysis
4.3. Value Chain Analysis
4.4. COVID-19 Impact on Market

Chapter 5. Neuroscience Antibodies & Assays Industry, By Type
5.1. Neuroscience Antibodies & Assays Market, By Type 2019-2026
5.2. Consumables
5.3. Instruments

Chapter 6. Neuroscience Antibodies & Assays Industry, By Application
6.1. Neuroscience Antibodies & Assays Market, By Application 2019-2026
6.2. Research
6.3. In Vitro Diagnostics
6.4. Drug Discovery and Development

Chapter 7. Neuroscience Antibodies & Assays Industry, By Region
7.1. Neuroscience Antibodies & Assays Market, By Region 2019-2026
7.1.1. North America
7.1.1.1. U.S
7.1.1.1. Canada
7.1.1.2. Mexico
7.1.2. Europe
7.1.2.1. U.K.
7.1.2.2. Germany
7.1.2.3. France
7.1.2.4. Rest of the Europe
7.1.3. Middle East & Africa (MEA)
7.1.3.1. GCC
7.1.3.2. North Africa
7.1.3.3. South Africa
7.1.3.4. Rest of MEA
7.1.4. Latin America (LATAM)
7.1.4.1. Brazil
7.1.4.2. Rest of LATAM
7.1.5. Asia Pacific (APAC)
7.1.5.1. India
7.1.5.2. China
7.1.5.3. Japan
7.1.5.4. Rest of the APAC

Chapter 8. Competitive Landscape
8.1.1. Key Strategies Adopted by Players
8.1.2. Market Share/Positioning Analysis

Chapter 9. Company Profiles
9.1. Thermo Fisher Scientific (US)
9.1.1. Company Overview
9.1.2. Product Offerings
9.1.3. Financial Performance
9.1.4. Recent Initiatives
9.2. Abcam (UK)
9.3. Bio-Rad (US)
9.4. Merck KGaA (Germany)
9.5. BioLegend (US)
9.6. Cell Signaling Technology (US)
9.7. F. Hoffmann-La Roche (Switzerland)
9.8. GenScript (China)
9.9. Rockland Immunochemicals (US)
9.10. Santa Cruz Biotechnology (US)
9.11. Siemens (Germany)
9.12. Tecan (Switzerland)

Chapter 10. Appendix
10.1. About Us
10.2. Glossary of Terms
10.3. Disclaimer

1. Thermo Fisher Scientific (US)
2. Abcam (UK)
3. Bio-Rad (US)
4. Merck KGaA (Germany)
5. BioLegend (US)
6. Cell Signaling Technology (US)
7. F. Hoffmann-La Roche (Switzerland)
8. GenScript (China)
9. Rockland Immunochemicals (US)
10. Santa Cruz Biotechnology (US)
11. Siemens (Germany)
12. Tecan (Switzerland)

1. This report provides in depth analysis for changing competitive dynamics and keeps you ahead of competitors
2. Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market
3. It provides a forward looking perspective on different factors driving or restraining market growth
4. It provides an eight-year forecast assessed on the basis of how the market is expected to grow
5. It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of various market segment
6. Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Select License Type
USD $4250
USD $6250
Connect With Us

+1-707-633-0404